Floatz logo

Casodex

Androgenetic Alopecia

HairDx, LLCPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Androgenetic Alopecia cohort.

Asset / SponsorPhaseRating
Finasteride
HairDx, LLC
Phase 1CC
Proxalutamide
Applied Biology, Inc.
N/AD

Same molecule, other indications

Casodex is also rated in:

prostate adenocarcinomaDormant
BB
Indicative ·
69 / 100
View asset →
triple-negative breast carcinomaDormant
BB
Indicative ·
67 / 100
View asset →
prostate cancerDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →